Protalix Biotherapeutics Inc (PLX)

Equity Ratio

64.72%

Quarterly · Period ending:

PLX logo

PLX Equity Ratio

Latest reported64.72%
PLX Quarterly Equity Ratio (78.43% → 64.72%)
High-resolution chart · PNG

PLX equity ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Protalix Biotherapeutics Inc Equity Ratio — Quarterly
Period endingEquity Ratio
88.876%
63.2572%
70.563%
79.4875%
79.2754%
78.5437%
77.5715%
80.006%
78.6583%
71.6056%
70.2884%
76.9231%
78.4314%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.